Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer

Over-expression of HER2 is generally considered to be a negative prognostic feature because it accompanies an increase in breast cancer mortality. However, the development of agents that specifically target HER2 has improved the management of patients with these tumours. This expert group used data...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahl, A., Singh, R., Wadhwa, J., Gupta, S., Ahmed, M., Uppal, P. N., Parikh, Purvish M., Aggarwal, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909284/
https://www.ncbi.nlm.nih.gov/pubmed/29721473
http://dx.doi.org/10.4103/sajc.sajc_111_18
_version_ 1783315869987766272
author Bahl, A.
Singh, R.
Wadhwa, J.
Gupta, S.
Ahmed, M.
Uppal, P. N.
Parikh, Purvish M.
Aggarwal, S.
author_facet Bahl, A.
Singh, R.
Wadhwa, J.
Gupta, S.
Ahmed, M.
Uppal, P. N.
Parikh, Purvish M.
Aggarwal, S.
author_sort Bahl, A.
collection PubMed
description Over-expression of HER2 is generally considered to be a negative prognostic feature because it accompanies an increase in breast cancer mortality. However, the development of agents that specifically target HER2 has improved the management of patients with these tumours. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at these practical consensus recommendations with regards to the use of these agents and the management of HER2 neu early breast cancer for the benefit of community oncologists.
format Online
Article
Text
id pubmed-5909284
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-59092842018-05-02 Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer Bahl, A. Singh, R. Wadhwa, J. Gupta, S. Ahmed, M. Uppal, P. N. Parikh, Purvish M. Aggarwal, S. South Asian J Cancer Original Article Over-expression of HER2 is generally considered to be a negative prognostic feature because it accompanies an increase in breast cancer mortality. However, the development of agents that specifically target HER2 has improved the management of patients with these tumours. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at these practical consensus recommendations with regards to the use of these agents and the management of HER2 neu early breast cancer for the benefit of community oncologists. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC5909284/ /pubmed/29721473 http://dx.doi.org/10.4103/sajc.sajc_111_18 Text en Copyright: © 2018 The South Asian Journal of Cancer http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Bahl, A.
Singh, R.
Wadhwa, J.
Gupta, S.
Ahmed, M.
Uppal, P. N.
Parikh, Purvish M.
Aggarwal, S.
Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer
title Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer
title_full Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer
title_fullStr Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer
title_full_unstemmed Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer
title_short Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer
title_sort practical consensus recommendations regarding the management of her2 neu positive early breast cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909284/
https://www.ncbi.nlm.nih.gov/pubmed/29721473
http://dx.doi.org/10.4103/sajc.sajc_111_18
work_keys_str_mv AT bahla practicalconsensusrecommendationsregardingthemanagementofher2neupositiveearlybreastcancer
AT singhr practicalconsensusrecommendationsregardingthemanagementofher2neupositiveearlybreastcancer
AT wadhwaj practicalconsensusrecommendationsregardingthemanagementofher2neupositiveearlybreastcancer
AT guptas practicalconsensusrecommendationsregardingthemanagementofher2neupositiveearlybreastcancer
AT ahmedm practicalconsensusrecommendationsregardingthemanagementofher2neupositiveearlybreastcancer
AT uppalpn practicalconsensusrecommendationsregardingthemanagementofher2neupositiveearlybreastcancer
AT parikhpurvishm practicalconsensusrecommendationsregardingthemanagementofher2neupositiveearlybreastcancer
AT aggarwals practicalconsensusrecommendationsregardingthemanagementofher2neupositiveearlybreastcancer

Ejemplares similares